A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers

Phase 1

Completed

• Conditions: Arthritis, Rheumatoid
• Interventions: Drug: CP 690,550 oral solutions

• Registration Number: NCT01023100
• Lead Sponsor: Pfizer

Brief Summary

This study will test the palatability of several different CP-690,550 oral preparations in trained product tester healthy volunteers.

Detailed Description

To develop a palatable pediatric oral solution dosage form of CP-690,550.

Study Timeline

• Study First Submitted: 2009-11-25
• Study First Submitted QC: 2009-11-30
• Study First Posted: 2009-12-02
• Study Start: 2010-03
• Primary Completion: 2010-03
• Study Completion: 2010-03
• Status Verified: 2010-06
• Last Update Submitted: 2010-06-14
• Last Update Posted: 2010-06-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• Trained healthy non-pregnant product testers, age 18-75

Exclusion Criteria

• Severe acute or chronic medical conditions, including hepatitis or tuberculosis infections or clinically significant laboratory abnormalities.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Open label	CP 690,550 oral solutions	-

Primary Outcome Measures

Name	Time	Method
A complete description of the sensory attributes of products (eg, aroma, flavor, texture, and mouthfeel).	3 months

Trial Locations

Locations (1)

Pfizer Investigational Site; 🇺🇸 Woburn, Massachusetts, United States